Ingo B. Runnebaum

Medicine · Health Sciences

55h-index11.7kcitations428works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(126), Endometrial and Cervical Cancer Treatments(64), BRCA gene mutations in cancer(40), PARP inhibition in cancer therapy(40), Endometriosis Research and Treatment(37)

Publications381 total

Long-term follow-up of the groningen international studies on sentinel nodes in vulvar cancer (GROINSS-V I & II): outcomes for patients with sentinel node metastases
International Journal of Gynecological Cancer·2026
Prevention of Severe Postoperative Pain after Breast Surgery Using Opioid-Sparing Analgesia with Intraoperative and Drain-Based Ropivacaine Infiltration: A Prospective Observational Study
Breast Care·2025Open Access
GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
EBioMedicine·2025· 1 citedOpen Access
Technik und Langzeitergebnisse eines kaudal gestielten Dermis-Lappens als autologe Implantat-Unterstützung bei der Brust-Sofort-Rekonstruktion nach subkutaner Mastektomie mit Reduktionsplastik
Geburtshilfe und Frauenheilkunde·2025
Atezolizumab versus Placebo in Kombination mit Bevacizumab und nicht-platinhaltiger Chemotherapie bei rezidivierendem Ovarialkarzinom: endgültige Gesamt- und progressionsfreie Überlebensergebnisse aus der AGO-OVAR 2.29/ENGOT-ov34-Studie
Geburtshilfe und Frauenheilkunde·2025
Minimally Invasive Surgery in Endometrial Cancer: Superior for Low-Risk and Comparable for High-Risk Cases in a 20-Year Cohort Study
Geburtshilfe und Frauenheilkunde·2025Open Access
Intergroup statement: opportunistic salpingectomy—molecular pathology, clinical outcomes and implications for practice (German Ovarian Cancer Commission, the North-Eastern German Society of Gynecologic Oncology (NOGGO), AGO Austria and AGO Swiss)
Archives of Gynecology and Obstetrics·2025· 2 citedOpen Access
Precision surgery for endometriosis: preventing chronic pelvic pain in patients with higher pre-operative pain scores and in patients of advanced age
Archives of Gynecology and Obstetrics·2025Open Access
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysis
International Journal of Surgery·2025· 5 citedOpen Access
Ovarian cancer prevention through opportunistic salpingectomy during abdominal surgeries: A cost-effectiveness modeling study
PLoS Medicine·2025· 7 citedOpen Access
Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial
Gynecologic Oncology·2024· 13 citedOpen Access
Ist eine starke 18F-FDG-Aufnahme einer uterinen Raumforderung im PET/CT ein Zeichen für Malignität?
Geburtshilfe und Frauenheilkunde·2024
Pre-debulking assessment of critical tumor spread to small bowel using the peritoneal cancer index (PCI) in primary advanced ovarian cancer
Geburtshilfe und Frauenheilkunde·2024
Accuracy of GynTect® Methylation Markers to Detect Recurrent Disease in Patients Treated for CIN3: A Proof-of-Concept Case-Control Study
Cancers·2024· 1 citedOpen Access
Reproductive outcomes after fertility-sparing surgery for cervical cancer - results of the multicenter FERTISS study
Gynecologic Oncology·2024· 8 cited
Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany
PLoS ONE·2024Open Access
949 Peritoneal carcinoma index (PCI) as a predictor for small bowel resection in advanced ovarian carcinoma surgery
2024
1087 Comparing patient-reported outcome measures (PROM) and parameters of radicality in surgical approaches for early high-risk cervical carcinoma: nerve-preserving vaginally assisted laparoscopic radical hysterectomy vs. laparoscopically assisted radical vaginal hysterectomy
2024
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial
International Journal of Gynecological Cancer·2023· 51 citedOpen Access
CCDC 2169443: Experimental Crystal Structure Determination
The Cambridge Structural Database·2023Open Access
page 1 of 20Next →

Frequent Co-authors

Matthias Dürst(16), Ignace Vergote(13), Brooke L. Fridley(12), Diether Lambrechts(12), Jenny Chang‐Claude(11), Peter A. Fasching(11), Ellen L. Goode(11), Jonathan P. Tyrer(11), Peter Hillemanns(10), Thilo Dörk(10), Graham G. Giles(10), Julie M. Cunningham(10), Alexander Hein(9), Shan Wang‐Gohrke(9), Arif B. Ekici(8), Jolanta Lissowska(8), R. Kreienberg(8), Frédéric Amant(7), Matthias W. Beckmann(7), Linda S. Cook(7)